Inventaire - your friends and communities are your best library

Phosphoproteomic analysis of Her2/neu signaling and inhibition

published in: Proceedings of the National Academy of Sciences of the United States of America

date of publication: 2006-06-19

language: inglese

Bibliographic databases:

Cites articles 39

Date

Title

Authors

1987-01-09

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
1987-07-01

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells
1990-02-01

The role of autophosphorylation in modulation of erbB-2 transforming function
1992-07-01

A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor
1992-08-07

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
1997-08-01

Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts
1998-09-29

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor
1998-06-01

Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential
1999-06-11

ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases
1999-03-01

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function
2000-06-01

The glioma-associated protein SETA interacts with AIP1/Alix and ALG-2 and modulates apoptosis in astrocytes
2000-04-01

Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions
2001-06

Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase
2001-02

Untangling the ErbB signalling network
2001-06-01

Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast
2002-05-03

The conformational plasticity of protein kinases
2002-05

GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways
2002-10-11

ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner
2003-07-24

Semaphorin 7A promotes axon outgrowth through integrins and MAPKs
2003-03

Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC),Properties of 13C-Substituted Arginine in Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)
2003-01-01

Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model?
2003-01-01

Genetics of dark skin in mice

, , ,
2004-10-01

Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex

, , ,
2004-09-07

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

, , , , , , ,
2004-09

Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics

,
2004-07-29

Advances to Bayesian network inference for generating causal networks from observational biological data

, ,
2004-06-04

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

, , , ,
2004-03-02

EGFR signaling to p120-catenin through phosphorylation at Y228.
2004-05-01

ALG-2, a multifunctional calcium binding protein?
2004-02-01

Inferring cellular networks using probabilistic graphical models
2004-10-01

Molecular basis of distinct interactions between Dok1 PTB domain and tyrosine-phosphorylated EGF receptor
2005-10

Mass spectrometry-based proteomics turns quantitative

Article -

Welcome to inventaire

The library of your friends and communities

Learn more